Those results indicate that there are a leptin-miR-205-MED1 and leptin-HER2-EGFR-MED1 axes, which can contribute to the understanding of the molecular mechanisms of tamoxifen resistance in obesity/hyperleptinemia states. The gene discussed is MED1; the disease is obesity disorder.